Publications

2021

Statement to EB148 on WHO reform: involvement of non-State actors in WHO’s governing bodies

Letter to Dr Tedros: Leadership and Advocacy for C-TAP

Statement to EB148 on expanding access to effective treatments for cancer and rare and orphan diseases, including medicines, vaccines, medical devices

Statement to EB148 on the COVID-19 response

Statement to EB148 on global strategy and plan of action on public health, innovation and intellectual property

Access to Internationally Controlled Essential Medicines in sub-Saharan Africa

2020

Joint HTA Assessment in Europe: Progress in 2020

Cross-country Cooperation Schemes: A fair-weather solution to the issue of access to medicines in Europe?

FACT SHEET: Impact and Knowledge of COVID-19 and related measures in rural Kenyan households

Making Medicines Authorisation Procedures Work for Patients

Clinical Trial Transparency in the Netherlands: Mapping Unreported Drug Trials

European Commission Intellectual Property Action Plan

Partners for Change

SRHC: Availability, Affordability and Stock-outs – Uganda 2019

Driving Change in Access to Medicines – Annual Report 2019

COVID-19 Technology Access Pool

SRHC: Availability, Affordability and Stockouts – Zambia 2019

Letter to Dr Tedros: The Challenge of Access to Insulin Amidst COVID-19

Results from the HSA Partnership’s Learning Agenda

The fight against COVID-19: let’s make public investments count for people

SRHC: Availability, Affordability and Stockouts- Kenya 2019

EU Priorities 2020-2024: Medicines policy that works for people

Patient-centred Advocacy: HAI’s Work in Europe 2020

Statement to EB146 on non-State actors on official relations with WHO

Statement to EB146 on Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property

Letter Regarding Proposed Amendments to Rules Governing the Involvement of Non-State Actors in WHO’s Governing Bodies

2019

Realities of access to medicines in the Netherlands: Commitments Rights and Obligations

Statement to the 69th Regional Committee World Health Organisation European Region (WHO-EURO)

Guidelines for socially responsible management of innovation

Fact or Fiction: What Healthcare Professionals Need to Know about Pharmaceutical Marketing in the European Union